Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
35 hedge funds and large institutions have $7.19M invested in Albireo Pharma Inc in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 9 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
12% less capital invested
Capital invested by funds: $8.19M → $7.19M (-$999K)
15% less funds holding
Funds holding: 41 → 35 (-6)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
67% less call options, than puts
Call options by funds: $21K | Put options by funds: $64K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMA
FNY Managed Accounts
New York
|
+$417K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$179K |
| 3 |
Renaissance Technologies
New York
|
+$172K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$96.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$56.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FNYS
First New York Securities
New York
|
-$453K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$66.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$62.6K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$48K |
| 5 |
RA
Royce & Associates
New York
|
-$34K |
ALBO Hedge Fund Activity: Q4 2014 in Review
35 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2014, worth a combined $7.19M — down 12% from $8.19M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALBO and 4 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 14 added.
The largest buyer was FNY Managed Accounts, adding an estimated $417K. The largest seller was First New York Securities, exiting entirely with an estimated $453K sold.
- 35 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2014, down from 41 in Q3 2014.
- Funds reported $7.19M of Albireo Pharma Inc stock for Q4 2014, down 12% quarter-over-quarter.
- 4 funds opened new Albireo Pharma Inc positions in Q4 2014 and 9 closed out, a net change of -5 holders.
- The largest Albireo Pharma Inc buyer in Q4 2014 was FNY Managed Accounts, an estimated $417K added.
- The largest Albireo Pharma Inc seller in Q4 2014 was First New York Securities, an estimated $453K sold.
Based on aggregated 13F filings for Q4 2014.